Introduction: Anxiety disorders, depressive disorders, and attention-deficit/hyperactivity disorder (ADHD) are some of the most common conditions that youths (<18 years old) receive mental health treatment for. These conditions are associated with high-risk substance use or substance use disorders (SUDs). This study sought to identify the proportion of youths (<18 years old) with anxiety disorders, depressive disorders, or ADHD as a primary diagnosis in community mental health centers (CMHCs) having co-occurring high-risk substance use or a SUD.
Methods: Analysis included binary logistic regression models using the Mental Health Client-Level Data 2017-2019 datasets which contains annual cross-sectional administrative data from mental health treatment facilities. The final sample included = 458,888 youths with an anxiety disorder as a primary diagnosis, = 570,388 youths with a depressive disorder as a primary diagnosis, and = 945,277 youths with ADHD as a primary diagnosis.
Results: In the subsample with anxiety as a primary diagnosis, approximately 5% of youth had high-risk substance use or a SUD. Approximately 10% of youth with depression as a primary diagnosis had high-risk substance use or a SUD. Among youth with ADHD as a primary diagnosis, 5% had high-risk substance use or a SUD. Odds of having a co-occurring high-risk substance use or SUD differed based on the youth's age, race and ethnicity, gender, and other mental health diagnoses.
Conclusions: Effective care for this high-need youth population at CMHCs will require mental health clinicians to possess knowledge and skills related to substance use treatment.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11732069 | PMC |
http://dx.doi.org/10.3389/frcha.2024.1340480 | DOI Listing |
Front Child Adolesc Psychiatry
March 2023
Department of Child Neuropsychiatry, A.S.L. CN1- Mondovì, Neuropsichiatria Infantile, Mondovì, Italy.
Research Aim: The aim of this study is to focus on the main neurophysiological aspects of attention-deficit/hyperactivity disorder (ADHD) and autism spectrum disorder (ASD) and the current pharmacological treatment used for the management of hyperactivity and attention deficits in children aged 6-20 years with a diagnosis of ASD, not associated with other genetic or epileptic disorders, such as Fragile X Syndrome (FXS), Tuberous Sclerosis, Kleefstra Syndrome or Angelman Syndrome.
Methods: This mini review was conducted according to the .I.
Front Child Adolesc Psychiatry
June 2023
Inserm UMR 1219, Bordeaux Population Health Research Center, PHARes Team, University of Bordeaux, Bordeaux, France.
Objective: This study aimed to identify the housing and psychosocial factors associated with mental health disorders in children aged 6-12 years living in sheltered homeless families in the Greater Paris area (France), with a view to guiding the development of actions that could improve their mental health.
Method: The cross-sectional study ENFAMS ("Enfants et familles sans logement") was conducted between January and May 2013 on a random sample of sheltered homeless families in the Greater Paris area using face-to-face questionnaires administered by trained interviewers and psychologists in 17 languages. The questionnaires collected data on socio-demographics, living conditions, and health characteristics for the child and one of the parent selected.
Front Child Adolesc Psychiatry
July 2023
Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Objective: This study examined the distinctiveness of Attention Deficit Hyperactivity Disorder-Inattentive (ADHD-I) and ADHD in context of Sluggish Cognitive Tempo (ADHD + SCT) utilizing the Attention Network Test (ANT) and Continuous Performance Test (CPT) as external validators. Due to the SCT characteristics of being sluggish, spacey, and slow to arouse, we hypothesized that SCT behavioral descriptors would be uniquely related to alerting/arousal mechanisms that the ANT is uniquely designed to capture, and that ADHD symptoms would be more highly associated with cognitive control on the CPT.
Method: We examined associations between baseline ANT and CPT scores for = 137 well-characterized, culturally and racially diverse youth with ADHD ( = 107) either medication naïve or washed out prior to testing and typically developing controls ( = 30) ages 6-17 years.
Front Child Adolesc Psychiatry
April 2024
School of Social Work, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
Introduction: Anxiety disorders, depressive disorders, and attention-deficit/hyperactivity disorder (ADHD) are some of the most common conditions that youths (<18 years old) receive mental health treatment for. These conditions are associated with high-risk substance use or substance use disorders (SUDs). This study sought to identify the proportion of youths (<18 years old) with anxiety disorders, depressive disorders, or ADHD as a primary diagnosis in community mental health centers (CMHCs) having co-occurring high-risk substance use or a SUD.
View Article and Find Full Text PDFFront Child Adolesc Psychiatry
November 2024
Applied Research & Evaluation, Child and Parent Resource Institute, Ministry of Children, Community and Social Services, London, ON, Canada.
Introduction: Psychotropic medication can be effective at stabilizing emotional and behavioural disturbances associated with physiological processes in children and youth. When medication benefits, indication or adverse effects are queried, deprescribing should be considered. Current guidelines for deprescribing are mainly for adults/elderly and largely theoretical, not practical, especially for polypharmacy.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!